Combined heterozygosity for methylenetetrahydrofolate reductase (MTHFR) mutations C677T and A1298C is associated with abruptio placentae but not withintrauterine growth restriction

Citation
Gs. Gebhardt et al., Combined heterozygosity for methylenetetrahydrofolate reductase (MTHFR) mutations C677T and A1298C is associated with abruptio placentae but not withintrauterine growth restriction, EUR J OB GY, 97(2), 2001, pp. 174-177
Citations number
21
Categorie Soggetti
Reproductive Medicine
Journal title
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
ISSN journal
03012115 → ACNP
Volume
97
Issue
2
Year of publication
2001
Pages
174 - 177
Database
ISI
SICI code
0301-2115(200108)97:2<174:CHFMR(>2.0.ZU;2-1
Abstract
Objective: This study was undertaken to investigate the involvement of MTHF R gene mutations C677T and A1298C implicated in vascular disease, in patien ts with abruptio placentae and intrauterine growth restriction (IUGR). Stud y Design: DNA was extracted from blood samples of 54 patients with placenta l vasculopathy (18 patients with abruptio placentae and 36 with IUGR) and 1 14 control patients and amplified by the polymerase chain reaction (PCR). T he resulting fragments were subjected to restriction enzyme analysis and re solved by gel electrophoresis. Results: A significant association could be demonstrated between mutation A 1298C and both-abruptio placentae and IUGR. Combined heterozygosity for mutations C677T and A1298C was detected in 22. 2% of abruptio placentae cases. Conclusions: Combined heterozygosity for MT HFR mutations C677T and A1298C may represent a genetic marker for abruptio placentae. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.